HCW-19502-29012
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 760 / TX
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Registered in v-safe
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-18
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-26
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Health check-in — day 0, dose 2Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal painAdult check-in
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Axillary mass — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches · Be unable to do your normal daily activitiesFree text: Mass under armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-09
- 2021-01-10
- 2021-01-16
- 2021-01-21
- 2021-01-28
-
2021-02-04
Survey response — day 28, dose 2MedDRA: Ageusia, Pain — Feeling: FairFree text: Body aches. Loss of tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
- 2021-02-18
- 2021-04-10
- 2021-07-08
-
2022-01-09
Survey response — 12 months, dose 2MedDRA: Cough, Headache, Oropharyngeal pain, Pain — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sore throat Headache Cough Body acheMedDRA releases: 2024-11 · check-in free text available
-
2022-01-09
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech |
Call center
3 call center cases
1 unsuccessful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Mass under armpit
Release 3 — day 28, dose 2
Symptoms: Body aches. Loss of taste
Release 10 — 12 months, dose 2
Symptoms: Sore throat Headache Cough Body ache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SRO | Axillary mass | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ○ | ○ | ○ |
✓ active code · ○ coded but marked inactive · blank = not in that release